10 AI News Updates Making Waves on Wall Street

7. Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP)

Number of Hedge Fund Holders: 4

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) develops innovative cell therapies for cancer, autoimmune, and infectious diseases, with a focus on immunotherapies and CAR T technologies.

On February 6, COEPTIS (NASDAQ:COEP) successfully raised an additional $5.7 million in its Series A Preferred Offering, bringing the total amount raised in the round to $10 million. Led by CJC Investment Trust, the financing includes a convertible Series A Preferred with shares priced at $8.00 each and a 15% equity interest in COEPTIS’ subsidiaries, SNAP Biosciences Inc. and GEAR Therapeutics Inc. The funds will be used to strengthen the company’s balance sheet, repay obligations, and support corporate purposes, with a focus on integrating AI and automation to improve research and operational processes.